Abstract
Autonomic dysfunction is common in neuro-critical care patients and may compromise the function of various organs. Among the many diseases causing or being associated with autonomic dysfunction are traumatic brain injury, cerebrovascular diseases, epilepsy, Guillain–Barré syndrome (GBS), alcohol withdrawal syndrome, botulism and tetanus, among many others. Autonomic dysfunction may afflict various organs and may involve hyper- or hypo-activity of the sympathetic or parasympathetic system. In this short overview, we address only a small number of neuro-intensive care diseases with autonomic dysfunction. In GBS, autonomic dysfunction is frequent and may account for increased mortality rates; rapid changes between sympathetic and parasympathetic hypo- or hyper-activity may cause life-threatening cardiovascular complications. Paroxysmal sympathetic hyperactivity occurs after brain injury, hypoxia and cerebrovascular and other events, causes paroxysmal tachycardia, hypertension, tachypnoea and hyperthermia and is associated with a poorer prognosis and prolonged intensive care treatment. Other, at times life-threatening autonomic complications with exaggerated sympathetic activity and compromised baroreflex sensitivity arise during the alcohol withdrawal syndrome triggered by abrupt cessation of alcohol consumption. Botulism and tetanus are examples of life-threatening autonomic dysfunction caused by bacterial neurotoxins. Common neurological diseases, such as epilepsy, stroke or subarachnoid haemorrhage, are also associated with autonomic dysfunction that can on occasion cause critical deterioration of disease severity and prognosis.
Similar content being viewed by others
References
Ablett JJL (1967) Analysis and main experinces in 82 patients treated in the leeds tetanus unit. In: Ellis M (ed) Symposium on Tetanus in Great Britain. Leeds General Infirmary, Boston Spa, pp 1–10
Alagbe-Briggs OT, Tinubu SA (2012) Tetanus—a case report with severe autonomic instability and: a review of the literature. Niger J Med 21:353–356
Anandan C, Khuder SA, Koffman BM (2017) Prevalence of autonomic dysfunction in hospitalized patients with Guillain–Barré syndrome. Muscle Nerve 56:331–333
Appenzeller O, Kornfeld M (1973) Acute pandysautonomia. Clinical and morphologic study. Arch Neurol 29:334–339
Arber N, Pras E, Copperman Y, Schapiro JM, Meiner V, Lossos IS, Militianu A, Hassin D, Pras E, Shai A, Moshkowitz M, Sidi Y (1994) Pacemaker endocarditis report of 44 cases and review of the literature. Medicine 73:299–305
Artal FJC (2017) Infectious diseases causing autonomic dysfunction. Clin Auton Res 28(1):67–81
Asbury AK, Arnason BG, Adams RD (1969) The inflammatory lesion in idiopathic polyneuritis. Medicine 48:173
Baguley IJ (2008) The excitatory:inhibitory ratio model (EIR model): an integrative explanation of acute autonomic overactivity syndromes. Med Hypotheses 70:26–35
Baguley IJ, Cameron ID, Green AM, Slewa-Younan S, Marosszeky JE, Gurka JA (2004) Pharmacological management of dysautonomia following traumatic brain injury. Brain Inj 18:409–417
Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID (2007) Gabapentin in the management of dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatry 78:539–541
Baguley IJ, Slewa-Younan S, Heriseanu RE, Nott MT, Mudaliar Y, Nayyar V (2007) The incidence of dysautonomia and its relationship with autonomic arousal following traumatic brain injury. Brain Inj 21:1175–1181
Bär KJ, Boettger MK, Boettger S, Grotelüschen M, Neubauer R, Jochum T, Baier V, Sauer H, Voss A (2006) Reduced baroreflex sensitivity in acute alcohol withdrawal syndrome and in abstained alcoholics. Drug Alcohol Depend 85:66–74
Barrons R, Roberts N (2010) The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. J Clin Pharm Ther 35:153–167
Beards SC, Lipman J, Bothma PA, Joynt GM (1994) Esmolol in a case of severe tetanus. Adequate haemodynamic control achieved despite markedly elevated catecholamine levels. South African journal of surgery. S Afr J Surg 32:33–35
Becker R, Benes L, Sure U, Hellwig D, Bertalanffy H (2000) Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 7:316–319
Bhagwanjee S, Bosenberg AT, Muckart DJ (1999) Management of sympathetic overactivity in tetanus with epidural bupivacaine and sufentanil: experience with 11 patients. Crit Care Med 27:1721–1725
Birchfield RI, Shaw CM (1964) Postural Hypotension in the Guillain–Barré Syndrome. Arch Neurol 10:149–157
Bullard DE (1987) Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 21:609–611
Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF (2001) Adynamic ileus in severe Guillain–Barré syndrome. Muscle Nerve 24:963–965
Cacoub P, Leprince P, Nataf P, Hausfater P, Dorent R, Wechsler B, Bors V, Pavie A, Piette JC, Gandjbakhch I (1998) Pacemaker infective endocarditis. Am J Cardiol 82:480–484
Chalela JA (2001) Pearls and pitfalls in the intensive care management of Guillain–Barré syndrome. Semin Neurol 21:399–405
Chen JT, Chen CC, Lin KP, Wang SJ, Wu ZA, Liao KK (1999) Botulism: heart rate variation, sympathetic skin responses, and plasma norepinephrine. Can J Neurol Sci 26:123–126
Coffey RJ, Edgar TS, Francisco GE, Graziani V, Meythaler JM, Ridgely PM, Sadiq SA, Turner MS (2002) Abrupt withdrawal from intrathecal baclofen: recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil 83:735–741
Cook TM, Protheroe RT, Handel JM (2001) Tetanus: a review of the literature. Br J Anaesth 87:477–487
Coomes TR, Smith SW (1997) Successful use of propofol in refractory delirium tremens. Ann Emerg Med 30:825–828
Cuny E, Richer E, Castel JP (2001) Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal Baclofen therapy. Brain Inj 15:917–925
de Jager AE, Minderhoud JM (1991) Residual signs in severe Guillain–Barré syndrome: analysis of 57 patients. J Neurol Sci 104:151–156
de Jager AE, Sluiter HJ (1991) Clinical signs in severe Guillain–Barré syndrome: analysis of 63 patients. J Neurol Sci 104:143–150
DeBellis R, Smith BS, Choi S, Malloy M (2005) Management of delirium tremens. J Intensive Care Med 20:164–173
Do D, Sheen VL, Bromfield E (2000) Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatry 69:832–833
Dolce G, Quintieri M, Leto E, Milano M, Pileggi A, Lagani V, Pignolo L (2008) Dysautonomia and clinical outcome in vegetative state. J Neurotrauma. doi: https://doi.org/10.1089/neu.2008.0536
Dundee JW, Morrow WF (1979) Labetalol in severe tetanus. BMJ 1:1121–1122
Dütsch M, Hilz MJ (2012) Epilepsy and Autonomic Regulation. In: Robertson D, Biaggioni I, Burnstock G, Low PA, Paton JFR (eds) Primer on the autonomic nervous system. Academic Press, Elsevier, London Waltham San Diego, pp 549–552
Dutta SR, Passi D, Singh M, Singh P, Sharma S, Sharma A (2016) Botulinum toxin the poison that heals: a brief review. Natl J Maxillofac Surg 7:10–16
Ferguson JA, Suelzer CJ, Eckert GJ, Zhou XH, Dittus RS (1996) Risk factors for delirium tremens development. J Gen Intern Med 11:410–414
Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, Galeas-Lopez JL, Quesada-Garcia G, Baguley IJ (2012) Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications. J Neurotrauma 29:1364–1370
Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G (2006) Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma 61:1129–1133
Flachenecker P (2007) Autonomic dysfunction in Guillain–Barré syndrome and multiple sclerosis. J Neurol 254[Suppl 2]:II96–101
Flachenecker P, Mullges W, Wermuth P, Hartung HP, Reiners K (1996) Eyeball pressure testing in the evaluation of serious bradyarrhythmias in Guillain–Barré syndrome. Neurology 47:102–108
Flachenecker P, Wermuth P, Hartung HP, Reiners K (1997) Quantitative assessment of cardiovascular autonomic function in Guillain–Barré syndrome. Ann Neurol 42:171–179
Girgin NK, Iscimen R, Gurbet A, Kahveci F, Kutlay O (2007) Dexmedetomidine sedation for the treatment of tetanus in the intensive care unit. Br J Anaesth 99:599–600
Green C, Baker T, Subramaniam A (2018) Predictors of respiratory failure in patients with Guillain–Barré syndrome: a systematic review and meta-analysis. Med J Aust 208:181–188
Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T (1997) Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med 23:893–895
Harms M (2011) Inpatient management of Guillain–Barré syndrome. Neurohospitalist 1:78–84
Haymaker WE, Kernohan JW (1949) The Landry–Guillain–Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature. Medicine (Baltimore) 28:59–141
Hecksel KA, Bostwick JM, Jaeger TM, Cha SS (2008) Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital. Mayo Clin Proc 83:274–279
Henriques Filho GT, Lacerda HR, Albuquerque A, Ximenes RA (2007) Sympathetic overactivity and arrhythmias in tetanus: electrocardiographic analysis. Rev Inst Med Trop Sao Paulo 49:17–22
Hilz MJ, Claus D, Bauer J, Neundorfer B (1990) Transcutaneous cardiac pacemaker for prevention and emergency therapy in neurologic intensive care patients. Der Nervenarzt 61:744–748
Hilz MJ, Moeller S, Akhundova A, Marthol H, Pauli E, De Fina P, Schwab S (2011) High NIHSS values predict impairment of cardiovascular autonomic control. Stroke 42:1528–1533
Hoes MJ (1979) The significance of the serum levels of vitamin B-1 and magnesium in delirium tremens and alcoholism. J Clin Psychiatr 40:476–479
Hoes MJ (1981) Plasma concentrations of magnesium and vitamin B-1 in alcoholism and delirium tremens. Pathogenic and prognostic implications. Acta Psychiatr Belg 81:72–84
Hughes RA, Wijdicks EF, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Sladky JT, Barohn RJ, Stevens JC (2005) Supportive care for patients with Guillain–Barré syndrome. Arch Neurol 62:1194–1198
Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM (1993) Intensive management and treatment of severe Guillain–Barré syndrome. Crit Care Med 21:433–446
Jeffery IA, Karim S (2017) Botulism. StatPearls [Internet]. Treasure Island, StatPearls Publishing LLC
Kahkonen S, Zvartau E, Lipsanen J, Bondarenko B (2011) Effects of alcohol withdrawal on cardiovascular system. Prog Neuropsychopharmacol Biol Psychiatry 35:550–553
Kanda T, Hayashi H, Tanabe H, Tsubaki T, Oda M (1989) A fulminant case of Guillain–Barré syndrome: topographic and fibre size related analysis of demyelinating changes. J Neurol Neurosurg Psychiatry 52:857–864
Khan A, Levy P, DeHorn S, Miller W, Compton S (2008) Predictors of mortality in patients with delirium tremens. Acad Emerg Med 15:788–790
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 351:478–484
Lee S, Jun GW, Jeon SB, Kim CJ, Kim JH (2016) Paroxysmal sympathetic hyperactivity in brainstem-compressing huge benign tumors: clinical experiences and literature review. Springerplus 5:340
Lichtenfeld P (1971) Autonomic dysfunction in the Guillain–Barré syndrome. Am J Med 50:772–780
Low PA, Benarroch EE (2008) Clinical autonomic disorders. Lippincott Williams & Wilkins, Baltimore Philadelphia
Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, Hu GH, Luo C, Lu YC (2010) Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma 27:1945–1950
Mathew MJ, Deepika A, Shukla D, Devi BI, Ramesh VJ (2016) Paroxysmal sympathetic hyperactivity in severe traumatic brain injury. Acta Neurochir 158:2047–2052
Mayo-Smith MF, Beecher LH, Fischer TL, Gorelick DA, Guillaume JL, Hill A, Jara G, Kasser C, Melbourne J (2004) Management of alcohol withdrawal delirium. An evidence-based practice guideline. Arch Intern Med 164:1405–1412
McCowan C, Marik P (2000) Refractory delirium tremens treated with propofol: a case series. Crit Care Med 28:1781–1784
McKeon A, Frye MA, Delanty N (2008) The alcohol withdrawal syndrome. J Neurol Neurosurg Psychiatry 79:854–862
McMicken D, Liss JL (2011) Alcohol-related seizures. Emerg Med Clin North Am 29:117–124
Merz B, Bigalke H, Stoll G, Naumann M (2003) Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res 13:337–338
Meyfroidt G, Baguley IJ, Menon DK (2017) Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol 16:721–729
Minahan RE Jr, Bhardwaj A, Traill TA, Hanley DF (1996) Stimulus-evoked sinus arrest in severe Guillain–Barré syndrome: a case report. Neurology 47:1239–1242
Mirijello A, D’Angelo C, Ferrulli A, Vassallo G, Antonelli M, Caputo F, Leggio L, Gasbarrini A, Addolorato G (2015) Identification and management of alcohol withdrawal syndrome. Drugs 75:353–365
Mirizzi G, Giannoni A, Bramanti F, Ripoli A, Varanini M, Bernardi L, Emdin M, Passino C (2013) A simple method for measuring baroreflex sensitivity holds prognostic value in heart failure. Int J Cardiol 169:e9–e11
Miyawaki E, Freeman R (1995) Peripheral autonomic neuropathies. In: korczyn A (ed) Handbook of autonomic nervous system dysfunction. Marcel Dekker, New York, pp 253–282
Mukerji S, Aloka F, Farooq MU, Kassab MY, Abela GS (2009) Cardiovascular complications of the Guillain–Barré syndrome. Am J Cardiol 104:1452–1455
Ormezzano O, Cracowski JL, Quesada JL, Pierre H, Mallion JM, Baguet JP (2008) EVAluation of the prognostic value of BARoreflex sensitivity in hypertensive patients: the EVABAR study. J Hypertens 26:1373–1378
Panegyres PK, Mastaglia FL (1989) Guillain–Barré syndrome with involvement of the central and autonomic nervous systems. Med J Aust 150:655–659
Patel MB, Goyal SK, Punnam SR, Pandya K, Khetarpal V, Thakur RK (2009) Guillain–Barré Syndrome with asystole requiring permanent pacemaker: a case report. J Med Case Rep 3:5
Patural H, Goffaux P, Paricio C, Emeriaud G, Teyssier G, Barthelemy JC, Pichot V, Roche F (2009) Infant botulism intoxication and autonomic nervous system dysfunction. Anaerobe 15:197–200
Perkes I, Baguley IJ, Nott MT, Menon DK (2010) A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol 68:126–135
Pfeiffer G (1999) Dysautonomie bei Guillain-Barré-Syndrom. Der Nervenarzt 70:136–148
Pfeiffer G, Netzer J (1997) Spectral analysis of heart rate and blood pressure in Guillain–Barré patients with respiratory failure. J Neurol Sci 150:39–48
Pfeiffer G, Schiller B, Kruse J, Netzer J (1999) Indicators of dysautonomia in severe Guillain–Barré syndrome. J Neurol 246:1015–1022
Pignolo L, Rogano S, Quintieri M, Leto E, Dolce G (2012) Decreasing incidence of paroxysmal sympathetic hyperactivity syndrome in the vegetative state. J Rehabil Med 44:502–504
Rabinstein AA, Benarroch EE (2008) Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol 10:151–157
Robertson D, Biaggioni I, Burnstock G, Low PA, Paton JFR (2012) Primer on the autonomic nervous system. Academic Press, Elsevier, London, Waltham, San Diego
Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF (2003) Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 34:705–712
Rocke DA, Wesley AG, Pather M, Calver AD, Hariparsad D (1986) Morphine in tetanus—the management of sympathetic nervous system overactivity. S Afr Med J 70:666–668
Rodrigo C, Fernando D, Rajapakse S (2014) Pharmacological management of tetanus: an evidence-based review. Crit Care 18:217
Ropper AH (1994) Intensive care of acute Guillain–Barré syndrome. Can J Neurol Sci 21:S23–S27
Ropper AH (2003) Critical care of Guillain–Barré syndrome. In: Ropper AH (ed) Neurological and neurosurgical intensive care. Lippincott Williams & Wilkins, Philadelphia
Ropper AH, Wijdicks EF (1990) Blood pressure fluctuations in the dysautonomia of Guillain–Barré syndrome. Arch Neurol 47:706–708
Roseman E, Aring CD (1941) Infectious polyneuritis. Medicine 20:463–494
Russo RN, O’Flaherty S (2000) Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury. J Paediatr Child Health 36:283–285
Sajid MS, Hebbar M, Baig MK, Li A, Philipose Z (2016) Use of prucalopride for chronic constipation: a systematic review and meta-analysis of published randomized, controlled trials. J Neurogastroenterol Motil 22:412–422
Sakakibara R, Uchiyama T, Kuwabara S, Mori M, Ito T, Yamamoto T, Awa Y, Yamaguchi C, Yuki N, Vernino S, Kishi M, Shirai K (2009) Prevalence and mechanism of bladder dysfunction in Guillain–Barré Syndrome. Neurourol Urodyn 28:432–437
Samadi M, Kazemi B, Golzari Oskoui S, Barzegar M (2013) Assessment of autonomic dysfunction in childhood Guillain–Barré syndrome. J Cardiovasc Thorac Res 5:81–85
Sander D, Hilz MJ, Ziemssen T (2015) Autonome störungen und vegetative krisen. In: Schwab S, Schellinger P, Werner C, Unterberg A, Werner H (eds) Neurologische intensivmedizin. Springer, Heidelberg, pp 634–649
Schmidt HB, Werdan K, Muller-Werdan U (2001) Autonomic dysfunction in the ICU patient. Curr Opin Crit Care 7:314–322
Schuckit MA (2014) Recognition and management of withdrawal delirium (delirium tremens). N Engl J Med 371:2109–2113
Schultis K (1976) Postaggressionsstoffwechsel als adaptation und als krankheit. In: Heberer G, Schultis K, Hoffmann K (eds) Postaggressionsstoffwechsel—Grundlagen, Klinik, Therapie. Schattauer Verlag, Stuttgart
Sykora M, Diedler J, Rupp A, Turcani P, Rocco A, Steiner T (2008) Impaired baroreflex sensitivity predicts outcome of acute intracerebral hemorrhage. Crit Care Med 36:3074–3079
Thomson AD, Cook CC, Touquet R, Henry JA (2002) The Royal College of Physicians report on alcohol: guidelines for managing Wernicke’s encephalopathy in the accident and emergency department. Alcohol Alcohol 37:513–521
Thomson AD, Marshall EJ (2006) The natural history and pathophysiology of Wernicke’s encephalopathy and Korsakoff’s psychosis. Alcohol Alcohol 41:151–158
Thwaites CL, Yen LM, Cordon SM, Thwaites GE, Loan HT, Thuy TT, White NJ, Soni N, Macdonald IA, Farrar JJ (2008) Effect of magnesium sulphate on urinary catecholamine excretion in severe tetanus. Anaesthesia 63:719–725
Tolonen J, Rossinen J, Alho H, Harjola VP (2013) Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med 20:425–427
Topakian R, Heibl C, Stieglbauer K, Dreer B, Nagl M, Knoflach P, Aichner FT (2009) Quantitative autonomic testing in the management of botulism. J Neurol 256:803–809
Torvik A, Lindboe CF, Rogde S (1982) Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 56:233–248
Truax BT (1984) Autonomic disturbances in the Guillain–Barré syndromé. Semin Neurol 4:462–468
Trujillo MH, Castillo A, Espana J, Manzo A, Zerpa R (1987) Impact of intensive care management on the prognosis of tetanus. Analysis of 641 cases. Chest 92:63–65
Tuck RR, McLeod JG (1981) Autonomic dysfunction in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 44:983–990
Turner MR, Gainsborough N (2001) Neuroleptic malignant-like syndrome after abrupt withdrawal of baclofen. J Psychopharmacol 15:61–63
Vita G, Girlanda P, Puglisi RM, Marabello L, Messina C (1987) Cardiovascular-reflex testing and single-fiber electromyography in botulism. A longitudinal study. Arch Neurol 44:202–206
Wasay M, Khealani BA, Talati N, Shamsi R, Syed NA, Salahuddin N (2005) Autonomic nervous system dysfunction predicts poor prognosis in patients with mild to moderate tetanus. BMC Neurol 5:2
Wesemann G, Grote E (1980) Pathophysiology of intra- and postoperative stress. In: Stoeckel H, Oyama T, Hack G (eds) Endocrinology in anaesthesia and surgery. Anaesthesiologie und intensivmedizin/anaesthesiology and intensive care medicine. Springer, Berlin, pp 10–23
Wijdicks EFM (2016) The Practice of emergency and critical care neurology. Oxford University Press, New York
Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins RP (1988) A prospective study of acute idiopathic neuropathy. II. Antecedent events. J Neurol Neurosurg Psychiatry 51:613–618
Zochodne DW (1994) Autonomic involvement in Guillain–Barré syndrome: a review. Muscle Nerve 17:1145–1155
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hilz, M.J., Liu, M., Roy, S. et al. Autonomic dysfunction in the neurological intensive care unit. Clin Auton Res 29, 301–311 (2019). https://doi.org/10.1007/s10286-018-0545-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-018-0545-8